Delivery Order SPE2DB20D3103-SPE2DB25FP1D2
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,811.26, is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract has a firm fixed price, a ceiling value of $20,670.76, and a performance period through May 16, 2025. There is no set-aside designation for this contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,830.06 contract is for the supply of XIFAXAN 550 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of May 7, 2025 and is not set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 mg tablets and has a ceiling value of $11,348.06. The ultimate completion date for this contract is May 13, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XIFAXAN 550 mg tablets, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $16,543.89 and is a firm-fixed-price delivery order contract, with a period of performance through May 15, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price, with a total ceiling value of $16,097.92, and a period of performance through May 29, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The award has a ceiling value of $14,640.12 and a completion date of May 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,987.59, is for the delivery of XIFAXAN 550 mg tablets. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $88,019.10, is for the supply of XIFAXAN 550 MG Tablets, a prescription medication. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,591.79 and a period of performance through July 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...